Corcept Therapeutics Executives Sell Shares
William Guyer, Chief Development Officer at Corcept Therapeutics, sold 678 shares of Common Stock on April 1, 2025, at a weighted average price of $114.5118 per share, totaling $77,639. Following the transaction, Guyer directly owns 5,487 shares of the company. The sale was conducted under a 10b5-1 plan adopted on November 27, 2024.
SEC Filing:
CORCEPT THERAPEUTICS INC [ CORT ] - Form 4 - Apr. 02, 2025
Reporter Name
Guyer William
Relationship
Chief Development Officer
Type
Sell
Amount
$77,639
SEC Filing
Form 4